Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells

K. Kuželová, D. Grebeňová, A. Holoubek, P. Röselová, A. Obr,

. 2014 ; 9 (3) : e92560.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 μM. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 μM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014452
003      
CZ-PrNML
005      
20150421092158.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0092560 $2 doi
035    __
$a (PubMed)24664099
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kuželová, Kateřina $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
245    10
$a Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells / $c K. Kuželová, D. Grebeňová, A. Holoubek, P. Röselová, A. Obr,
520    9_
$a P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 μM. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 μM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.
650    _2
$a faktory depolymerizující aktin $x chemie $x metabolismus $7 D051339
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a krevní buňky $x cytologie $x účinky léků $7 D001773
650    _2
$a buněčná adheze $x účinky léků $7 D002448
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a disulfidy $x metabolismus $x farmakologie $7 D004220
650    _2
$a fibronektiny $x metabolismus $7 D005353
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a umlčování genů $7 D020868
650    _2
$a hematopoéza $x účinky léků $7 D006410
650    _2
$a lidé $7 D006801
650    _2
$a intracelulární prostor $x účinky léků $x metabolismus $7 D042541
650    _2
$a leukemie $x patologie $7 D007938
650    _2
$a lymfom $x patologie $7 D008223
650    _2
$a naftoly $x metabolismus $x farmakologie $7 D009284
650    _2
$a fosforylace $x účinky léků $7 D010766
650    _2
$a inhibitory proteinkinas $x metabolismus $x farmakologie $7 D047428
650    _2
$a malá interferující RNA $x genetika $7 D034741
650    _2
$a serin $x metabolismus $7 D012694
650    _2
$a p21 aktivované kinasy $x antagonisté a inhibitory $x nedostatek $x genetika $7 D054462
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Grebeňová, Dana $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Holoubek, Aleš $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Röselová, Pavla $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Obr, Adam $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 3 (2014), s. e92560
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24664099 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150421092456 $b ABA008
999    __
$a ok $b bmc $g 1072033 $s 897330
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 3 $d e92560 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20150420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...